KU Cancer Center
@KUcancercenter
We are transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our patient care program
ID:71275139
http://www.kucancercenter.org 03-09-2009 15:06:10
11,0K Tweets
5,9K Followers
1,7K Following
Follow People
At a live virtual event, Leyla Shune MD discussed the emergence of talquetamab-tgvs (Talvey) for patients with relapsed/refractory #MultipleMyeloma . Learn more via Targeted Oncology ➜ bit.ly/4b9XWgN.
🩸 Calling all #hematology trainees! Do you want to join a dynamic community driving innovation & advocacy in hematology? Apply today for one of ten available positions on the ASH Trainee Council!
📅 The application deadline is April 30: ow.ly/9UA150Rn3T7
#ASHTrainee
#PancreaticCancer #ClinicalTrials are necessary to determine whether new treatments are beneficial to people living with the disease. Learn about a multicenter, phase 2 trial looking at a new drug combination: bit.ly/3ILKm7d or email [email protected].
'There's a race to understand how we can screen all women earlier for #OvarianCancer . If we could diagnose women earlier, we could save many lives.' - Diane Mahoney, PhD, APRN
Read more from Dr. Mahoney on the KU Cancer Center blog ➜ bit.ly/49VRR6U.
This year’s #kuBMTsymposium is ending but keep the conversation going on X! Share your favorite highlights + thoughts of today’s program. Learn more about blood cancers: bit.ly/3eeHwYT. #KUBloodCancer
Dr. Joseph McGuirk - @KUCancerCenter – is leading the final Q&A and Wrap Up Session at today’s #kuBMTsymposium . #KUBloodCancer
Happening now at the #kuBMTsymposium : Kristin Holoch, MD, FACOG - The University of Kansas Health System is presenting “Fertility Preservation in Cancer Patients.” #KUBloodCancer
At 2:55 pm, don’t miss the #kuBMTsymposium talk from City of Hope’s Elizabeth Budde, MD, PhD: “CAR-T Cell Therapy for Acute Myeloid Leukemia.” #Immunotherapy #AML
#kuBMTsymposium talk at 2:30 from @kucancercenter’s Haitham Abdelhakim, MD: “Immunotherapies for Acute Myeloid Leukemia.” #KUBloodCancer #AML
#kuBMTsymposium attendees: At 1:05 Anthony Sung, MD, from Duke Cancer is talking about “Pre-, Peri-, and Post-Transplant Optimization Programs.”
#kuBMTsymposium attendees: Have you registered for the Immune Cell Effector Therapy (ICE-T) Symposium on July 27th? Learn more and register today ➜ bit.ly/4arlldc.
If you’re attending the #kuBMTsymposium - Starting at 11:50 hear from National Cancer Institute’s Christopher Kanakry, MD, presenting “Haploidentical Transplantation Using Post-Transplantation Cyclophosphamide: Mechanisms and Clinical Optimization.”
What are the newest advancements in CAR T-cell therapy for #MultipleMyeloma ? Learn more from Binod Dhakal, MD, MS - Medical College of Wisconsin starting now at the #kuBMTsymposium .
Going on now: Dr. Joseph McGuirk - @KUCancerCenter – is leading the Q&A at today’s #kuBMTsymposium .